Two mutations associated with macrolide resistance in treponema pallidum: Increasing prevalence and correlation with molecular strain type in Seattle, Washington

Sexually Transmitted Diseases

Volumn 39, Issue 12, 2012, Pages 954-958

  Grimes, Matthew ^a   Sahi, Sharon K ^b   Godornes, B Charmie ^c   Tantalo, Lauren C ^b   Roberts, Neal ^d   Bostick, David ^d   Marra, Christina M ^b   Lukehart, Sheila A ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DNA 23S; MACROLIDE;

ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; PREVALENCE; SYPHILIS; TREPONEMA PALLIDUM; UNITED STATES;

AZITHROMYCIN; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; POINT MUTATION; PREVALENCE; SYPHILIS; TREPONEMA PALLIDUM; WASHINGTON;

EID: 84870244109     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31826ae7a8     Document Type: Conference Paper

References (24)

1. Centers for Disease Control. STD surveillance report. MMWR Morb Mortal Wkly Rep 2011.
2. Tucker JD, Yin YP, Wang B, et al. An expanding syphilis epidemic in China: Epidemiology, behavioural risk and control strategies with a focus on low-tier female sex workers and men who have sex with men. Sex Transm Infect 2011; 87(suppl 2):ii16Yii18.
3. Kiddugavu MG, Kiwanuka N, Wawer MJ, et al. Effectiveness of syphilis treatment using azithromycin and/or benzathine penicillin in Rakai, Uganda. Sex Transm Dis 2005; 32:1-6.
4. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353:1236-1244.
5. Hook EWI, Behets F, Van Damme K, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010; 201:1729-1735.
6. Mitchell SJ, Engelman J, Kent CK, et al. Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis 2006; 42:337-345.
7. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351:154-158.
8. Stamm LV, Bergen HL. A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 2000; 44:806-807.
9. Matejkova P, Flasarova M, Zakoucka H, et al. Macrolide treatment failure in a case of secondary syphilis: A novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol 2009; 58:832-836.
10. Martin IE, Gu W, Yang Y, et al. Macrolide reistance and molecular types of Treponema pallidum causing primary syphilis in Shanghai, China. Clin Infect Dis 2009; 49:515-521.
11. Marra CM, Maxwell CL, Tantalo L, et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: Does HIV status matter? Clin Infect Dis 2004; 38:1001-1006.
12. Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893-899.
13. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features. J Infect Dis 2004; 189:369-376.
14. Marra CM, Sahi SK, Tantalo L, et al. Enhanced molecular typing of Treponema pallidum: Geographical distribution of strain types and association with neurosyphilis. J Infect Dis 2010; 202:1380-1388.
15. Marra CM, Colina AP, Godornes C, et al. Antibiotic selection may contribute to increases in macrolide-resistant Treponema pallidum. J Infect Dis 2006; 194:1771-1773.
16. Centers for Disease Control. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 26-38.
17. Seattle King County Public Health. 2010 King County Sexually Transmitted Diseases Epidemiology Report. Available at: http://www.kingcounty.gov/ healthservices/health/communicable/std/statistics.aspx 2010. Accessed June 26, 2012.
18. Katz KA, Klausner JD. Azithromycin resistance in Treponema pallidum. Curr Opin Infect Dis 2008; 21:83-91.
19. Tipple C, McClure MO, Taylor GP. High prevalence of macrolide resistant Treponema pallidum strains in a London centre. Sex Transm Infect 2011; 87:486-488.
20. Martin IE, Tsang RS, Sutherland K, et al. Molecular characterization of syphilis in patients in Canada: Azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J Clin Microbiol 2009; 47:1668-1673.
21. Zhou P, Li K, Lu H, et al. Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis 2010; 37:726-729.
22. Van Damme K, Behets F, Ravelomanana N, et al. Evaluation of azithromycin resistance in Treponema pallidum specimens from Madagascar. Sex Transm Dis 2009; 36:775-776.
23. Majid N, Bollen L, Morineau G, et al. Syphilis among female sex workers in Indonesia: Need and opportunity for intervention. Sex Transm Infect 2010; 86:377-383.
24. Fegan D, Glennon MJ, Thami Y, et al. Resurgence of yaws in Tanna, Vanuatu: Time for a new approach? Trop Doct 2010; 40:68-69.